Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 2/20 | 0.77 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.68 |
| ▸ | FEN1 | P39748 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.62 |
| ▸ | SRD5A2 | P31213 | 4/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4437033 | 0.94 | MMP1 (0.71) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317520 | 0.92 | MMP1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317521 | 0.92 | MMP1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317519 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317525 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19305819 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317524 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317522 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL10534992 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 | |
| SCHEMBL19317523 | 0.90 | L3MBTL1 (0.68) | MMP1ERCC5FEN1POLBPARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403459-B | Preparation method of 1, 4-dicarbonyl compound | 广州自远生物科技有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-115403459-A | Preparation method of 1, 4-dicarbonyl compound | 广州自远生物科技有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | OXFORD PERFORMANCE MATERIALS, INC | 2017-09-07 | — | — | US | disclosed |
| EP-0262919-B1 | PREPARATION OF ARYL CARBONYL COMPOUNDS | RAYCHEM LIMITED (GB) | 1991-09-11 | — | — | EP | disclosed |
| US-4898983-A | FRIEDEL-CRAFTS PROCESS; LEWIS ACIDS, BY-PRODUCT INHIBITION; ACID HALIDES, ACTIVE HYDROGEN AROMATIC COMPONENTS; CONTROLLING AGENTS | RAYCHEM LIMITED (GB) | 1990-02-06 | — | — | US | disclosed |
| EP-0262919-A2 | Preparation of aryl carbonyl compounds | RAYCHEM LIMITED (GB) | 1988-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253696-A1 | METHOD FOR MAKING POLYARYLALIPHATICETHERKETONE POLYMERS AND COPOLYMERS THEREOF | COASY, FRK, PBK | MMP1 3624/4885ERCC5 2918/4885FEN1 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.